Ord Minnett Reaffirms Their Buy Rating on Meteoric Resources NL (MEI)
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Hope covers the Basic Materials sector, focusing on stocks such as Boss Energy , Lotus Resources Limited, and Lynas Rare Earths . According to TipRanks, Hope has an average return of 10.8% and a 57.43% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Meteoric Resources NL with a A$0.27 average price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
FOOD & LIFE COMPANIES (SGLOF) Initiated with a Buy at J.P. Morgan
J.P. Morgan analyst Ami Terai initiated coverage with a Buy rating on FOOD & LIFE COMPANIES on July 25 and set a price target of Yen8,500.00. The company's shares closed last Tuesday at $17.82. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Terai is a 2-star analyst with an average return of 2.6% and a 16.67% success rate. Terai covers the Consumer Cyclical sector, focusing on stocks such as Skylark Holdings Co, MonotaRO Co, and ZOZO. FOOD & LIFE COMPANIES has an analyst consensus of Strong Buy, with a price target consensus of $52.17. Based on FOOD & LIFE COMPANIES' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $104.67 billion and a net profit of $5.74 billion. In comparison, last year the company earned a revenue of $90.46 billion and had a net profit of $4.02 billion
Business Insider
an hour ago
- Business Insider
Nomura Sticks to Its Buy Rating for Dr. Reddy's Laboratories Ltd. (DRREDDY)
In a report released on July 25, Saion Mukherjee from Nomura maintained a Buy rating on Dr. Reddy's Laboratories Ltd., with a price target of INR1,660.00. The company's shares closed last Friday at INR1,277.90. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mukherjee covers the Healthcare sector, focusing on stocks such as Alkem Laboratories Ltd., Cipla Ltd, and Dr. Reddy's Laboratories Ltd.. According to TipRanks, Mukherjee has an average return of 15.0% and a 75.00% success rate on recommended stocks. Currently, the analyst consensus on Dr. Reddy's Laboratories Ltd. is a Hold with an average price target of INR1,236.44, representing a -3.24% downside. In a report released on July 25, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a INR1,416.00 price target. Based on Dr. Reddy's Laboratories Ltd.'s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of INR85.06 billion and a net profit of INR15.94 billion. In comparison, last year the company earned a revenue of INR70.83 billion and had a net profit of INR13.07 billion
Business Insider
an hour ago
- Business Insider
Warburg Research Sticks to Their Buy Rating for PUMA SE NPV (PMMAF)
Warburg Research analyst Jörg Philipp Frey maintained a Buy rating on PUMA SE NPV on July 25 and set a price target of €60.00. The company's shares closed last Friday at $25.15. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Philipp Frey is an analyst with an average return of -2.2% and a 43.30% success rate. Philipp Frey covers the Consumer Cyclical sector, focusing on stocks such as PUMA SE NPV, Hugo Boss, and Zalando. Currently, the analyst consensus on PUMA SE NPV is a Hold with an average price target of $34.38, a 36.70% upside from current levels. In a report released on July 25, Deutsche Bank also maintained a Buy rating on the stock with a €34.00 price target.
